ArticleBreast cancer research : BCR2023

Head-to-head comparison of perfluorobutane contrast-enhanced US and multiparametric MRI for breast cancer: a prospective, multicenter study.

Manlin Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.